IRCT20210519051345N43招募中Unknown
Fasted-state in vivo bioequivalence study of Gliclazide 60 mg sustained release tablet manufactured by AaniDarman compared with innovator product
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- All
入选标准
- •General Health (in terms of Liver, Heart and Kidney)
- •Age (18-59 years)
排除标准
- •History of cardiovascular disease, liver and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
尚未招募
Unknown
Bioequivalence study of Gliclazide 60 mg tabletIRCT20210519051345N63Tabriz University of Medical Sciences24
尚未招募
Unknown
In vivo Bioequivalence study of Levodopa/benserazide tabletsIRCT20220211053992N32Tabriz University of Medical Sciences24
尚未招募
Unknown
In vivo Bioequivalence study of Levodopa/benserazide tabletsIRCT20220211053992N34Tabriz University of Medical Sciences24
尚未招募
不适用
Investigating the in vivo bioequivalence of Celecoxib 100 mg tabletIRCT20210519051345N15Tabriz University of Medical Sciences24
招募中
Unknown
Investigating the in vivo bioequivalence of Sildenafil 100 mgIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N28Tabriz University of Medical Sciences24